[Skip to Content]
[Skip to Content Landing]
Citations 0
Letters
February 24, 2010

Event Rates in Trials of Patients With Type 2 Diabetes—Reply

JAMA. 2010;303(8):732-733. doi:10.1001/jama.2010.139

In Reply: Both letters correctly point to heterogeneity in the “Fatal and nonfatal MI” classification in the Table in our Commentary. Because the cited ADVANCE and PROACTIVE publications did not provide the fatal and nonfatal MI incidence rates, in the Table we instead used nonfatal MI incidence for those 2 studies, but this was unfortunately not made clear. In addition, in the control group for the ADVANCE trial, the MI rate should have been 5.6 rather than 5.5. A correction appears in this issue of JAMA.

First Page Preview View Large
First page PDF preview
First page PDF preview
×